Cargando…
Vedolizumab, a gut-specific monoclonal antibody, renews hope for an alternative to anti-TNF therapy in inflammatory bowel diseases
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hellenic Society of Gastroenterology
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982639/ https://www.ncbi.nlm.nih.gov/pubmed/24733411 |
| _version_ | 1782311207552679936 |
|---|---|
| author | Rezaie, Ali |
| author_facet | Rezaie, Ali |
| author_sort | Rezaie, Ali |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3982639 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Hellenic Society of Gastroenterology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39826392014-04-14 Vedolizumab, a gut-specific monoclonal antibody, renews hope for an alternative to anti-TNF therapy in inflammatory bowel diseases Rezaie, Ali Ann Gastroenterol Clinical Opinion Hellenic Society of Gastroenterology 2014 /pmc/articles/PMC3982639/ /pubmed/24733411 Text en Copyright: © Hellenic Society of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Clinical Opinion Rezaie, Ali Vedolizumab, a gut-specific monoclonal antibody, renews hope for an alternative to anti-TNF therapy in inflammatory bowel diseases |
| title | Vedolizumab, a gut-specific monoclonal antibody, renews hope for an alternative to anti-TNF therapy in inflammatory bowel diseases |
| title_full | Vedolizumab, a gut-specific monoclonal antibody, renews hope for an alternative to anti-TNF therapy in inflammatory bowel diseases |
| title_fullStr | Vedolizumab, a gut-specific monoclonal antibody, renews hope for an alternative to anti-TNF therapy in inflammatory bowel diseases |
| title_full_unstemmed | Vedolizumab, a gut-specific monoclonal antibody, renews hope for an alternative to anti-TNF therapy in inflammatory bowel diseases |
| title_short | Vedolizumab, a gut-specific monoclonal antibody, renews hope for an alternative to anti-TNF therapy in inflammatory bowel diseases |
| title_sort | vedolizumab, a gut-specific monoclonal antibody, renews hope for an alternative to anti-tnf therapy in inflammatory bowel diseases |
| topic | Clinical Opinion |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982639/ https://www.ncbi.nlm.nih.gov/pubmed/24733411 |
| work_keys_str_mv | AT rezaieali vedolizumabagutspecificmonoclonalantibodyrenewshopeforanalternativetoantitnftherapyininflammatoryboweldiseases |